Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.96%79.76M | 13.90%87.72M | -5.33%61.03M | -0.00%304.67M | 3.23%87.91M | -2.68%75.28M | 6.03%77.02M | -7.29%64.47M | -14.68%304.68M | 9.70%85.15M |
| Cost of revenue | 5.53%70.9M | 10.20%74.04M | -9.80%53.86M | -1.30%262.45M | -4.39%68.37M | 0.30%67.19M | 3.98%67.18M | -4.94%59.71M | -10.04%265.92M | 3.11%71.51M |
| Gross profit | 9.56%8.86M | 39.13%13.69M | 50.80%7.17M | 8.93%42.22M | 43.19%19.53M | -21.93%8.09M | 22.51%9.84M | -29.27%4.75M | -36.97%38.76M | 65.04%13.64M |
| Operating expense | -24.59%1.43M | 23.30%1.32M | 38.60%1.61M | -49.41%3.72M | 22.70%2.71M | -8.79%1.9M | -20.34%1.07M | -31.19%1.16M | -3.91%7.35M | -9.47%2.21M |
| Selling and administrative expenses | -5.86%2.02M | 1.50%2.03M | 0.00%2.24M | -7.17%8.39M | -18.77%2.23M | -7.09%2.15M | 4.17%2M | 8.54%2.24M | 3.48%9.03M | -1.97%2.74M |
| -General and administrative expense | -5.86%2.02M | 1.50%2.03M | 0.00%2.24M | -7.17%8.39M | -18.77%2.23M | -7.09%2.15M | 4.17%2M | 8.54%2.24M | 3.48%9.03M | -1.97%2.74M |
| Other operating expenses | -12.55%411K | --278K | --12K | -166.67%-56K | 803.83%2.83M | --470K | ---- | ---- | -109.63%-21K | 268.28%313K |
| Total other operating income | 39.17%1M | 6.26%985K | -40.32%644K | 177.82%4.61M | 177.63%2.35M | 211.69%720K | 61.78%927K | 185.45%1.08M | 28.11%1.66M | 397.06%845K |
| Operating profit | 20.03%7.43M | 41.07%12.36M | 54.73%5.56M | 22.59%38.5M | 47.14%16.83M | -25.24%6.19M | 31.14%8.76M | -28.62%3.6M | -41.67%31.4M | 96.21%11.44M |
| Net non-operating interest income (expenses) | 83.81%-45K | 32.90%-208K | 94.85%-5K | -111.38%-873K | -161.11%-188K | -1,012.00%-278K | -1.64%-310K | -781.82%-97K | 47.59%-413K | 50.00%-72K |
| Non-operating interest income | 15.79%440K | -16.37%327K | 19.22%552K | 4.34%1.73M | 8.52%497K | -14.22%380K | 18.13%391K | 8.43%463K | 68.43%1.66M | 34.71%458K |
| Non-operating interest expense | -26.29%485K | -23.68%535K | -0.54%557K | 25.68%2.6M | 29.25%685K | 40.60%658K | 10.22%701K | 27.85%560K | 16.86%2.07M | 9.50%530K |
| Net investment income | -140.57%-43K | 53.62%106K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -2,394.07%-3.1M | 121.99%135K | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | 5,915.38%3.13M | ---- | ---- | ---- | ---- | -89.78%52K | ---- |
| Less:Other special charges | ---- | ---- | ---- | 83.42%-31K | ---- | ---- | ---- | ---- | -62.61%-187K | ---- |
| Other non-operating income (expenses) | -12K | 111.11%23K | 87.94%-207K | |||||||
| Income before tax | 24.93%7.39M | 43.77%12.15M | 58.87%5.56M | 11.22%34.51M | 46.42%16.64M | -28.39%5.91M | 32.57%8.45M | -30.40%3.5M | -38.91%31.02M | 231.96%11.36M |
| Income tax | -7.36%2.5M | 53.49%3.67M | 35.33%1.95M | 23.98%12.79M | 78.09%6.25M | 8.64%2.7M | 6.45%2.39M | -30.43%1.44M | -41.23%10.31M | -42.36%3.51M |
| Net income | 52.13%4.88M | 39.93%8.48M | 75.30%3.61M | 4.87%21.72M | 32.27%10.39M | -44.37%3.21M | 46.79%6.06M | -30.37%2.06M | -37.69%20.71M | 394.56%7.85M |
| Net income continuous operations | 52.13%4.88M | 39.93%8.48M | 75.30%3.61M | 4.87%21.72M | 32.27%10.39M | -44.37%3.21M | 46.79%6.06M | -30.37%2.06M | -37.69%20.71M | 394.56%7.85M |
| Noncontrolling interests | 840.00%222K | -36.70%288K | 242.57%507K | -65.51%109K | -23,250.00%-463K | -128.57%-30K | 1,066.67%455K | -12.94%148K | -81.18%316K | 100.98%2K |
| Net income attributable to the company | 43.87%4.66M | 46.15%8.19M | 62.36%3.11M | 5.96%21.61M | 38.20%10.85M | -42.80%3.24M | 37.07%5.61M | -31.43%1.91M | -35.37%20.39M | 418.89%7.85M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 43.87%4.66M | 46.15%8.19M | 62.36%3.11M | 5.96%21.61M | 38.20%10.85M | -42.80%3.24M | 37.07%5.61M | -31.43%1.91M | -35.37%20.39M | 418.89%7.85M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 43.81%0.0151 | 46.41%0.0265 | 62.90%0.0101 | 5.91%0.0699 | 38.19%0.0351 | -42.62%0.0105 | 37.12%0.0181 | -31.11%0.0062 | -35.36%0.066 | 417.50%0.0254 |
| Diluted earnings per share | 43.81%0.0151 | 46.41%0.0265 | 62.90%0.0101 | 5.91%0.0699 | 38.19%0.0351 | -42.62%0.0105 | 37.12%0.0181 | -31.11%0.0062 | -35.36%0.066 | 417.50%0.0254 |
| Dividend per share | 0 | 50.00%0.03 | 0 | 0.00%0.02 | 0 | 0 | 0.02 | 0 | 100.00%0.02 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.